Pharmx Technologies Ltd (PHX) — Cash Flow Quality Index

Latest as of June 2022: 5.80x

Pharmx Technologies Ltd (PHX) has a Cash Flow Quality Index of 5.80x as of June 2022. Operating cash flow of AU$478.50K exceeds net income of AU$82.50K, indicating high earnings quality where cash backs reported profits. Explore PHX cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

5.80x
Operating CF / Net Income

Operating Cash Flow

AU$478.50K
AUD

Net Income

AU$82.50K
AUD

Data as of

Jun 2022
Most recent filing

Pharmx Technologies Ltd Cash Flow Quality Index (2007–2022)

Historical Cash Flow Quality Index for Pharmx Technologies Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PHX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Pharmx Technologies Ltd (2007–2022)

Year-by-year earnings quality comparison for Pharmx Technologies Ltd. For live market cap and the full company financial profile, see Pharmx Technologies Ltd market cap and net worth.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2022 121.83x AU$2.19 Million AU$18.00K ▲ +4103.7%
2021 2.90x AU$3.16 Million AU$1.09 Million ▲ +38.2%
2020 2.10x AU$369.00K AU$176.00K ▲ +58.5%
2018 1.32x AU$332.00K AU$251.00K ▲ +102.8%
2016 -47.04x AU$-1.27 Million AU$27.00K ▼ -6264.2%
2015 0.76x AU$3.53 Million AU$4.63 Million ▼ -42.6%
2014 1.33x AU$5.68 Million AU$4.27 Million ▲ +27.7%
2013 1.04x AU$6.61 Million AU$6.36 Million ▲ +34.4%
2012 0.77x AU$4.67 Million AU$6.03 Million ▼ -63.1%
2011 2.10x AU$3.67 Million AU$1.75 Million ▲ +4.6%
2010 2.01x AU$2.26 Million AU$1.13 Million ▼ -69.0%
2007 6.48x AU$2.65 Million AU$409.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.